March 04, 2015 9:04 AM ET

Healthcare Equipment and Supplies

Company Overview of Tandem Diabetes Care, Inc.

Company Overview

Tandem Diabetes Care, Inc., a medical device company, focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes in the United States. The company’s products include t:slim Insulin Delivery System that comprises t:slim pump, its disposable cartridge, and an infusion set; and t:connect Diabetes Management Application, a PC and Mac-compatible, cloud-based data management application that provides a visual way to display therapy management data from the pump and supported blood glucose meters for users, their caregivers, and their healthcare providers. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabe...

11045 Roselle Street

San Diego, CA 92121

United States

Founded in 2006

437 Employees

Phone:

858-366-6900

Key Executives for Tandem Diabetes Care, Inc.

Chief Executive Officer, President and Director
Age: 62
Total Annual Compensation: $472.1K
Chief Financial Officer, Principal Accounting Officer and Treasurer
Age: 48
Total Annual Compensation: $362.6K
Chief Administrative Officer
Age: 35
Total Annual Compensation: $275.2K
Compensation as of Fiscal Year 2013.

Tandem Diabetes Care, Inc. Key Developments

Tandem Diabetes Care, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the Year Ending December 31, 2015

Tandem Diabetes Care, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported net loss of $18,465,000 or $0.78 per basic and diluted share on sales of $17,889,000 against net loss of $23,613,000 or $2.14 per basic and diluted share on sales of $10,245,000 a year ago. Operating loss of $17,502,000 compared to $16,463,000 a year ago. Loss before taxes of $18,394,000 compared to $23,613,000 a year ago. For the full year, the company reported net loss of $79,524,000 or $3.42 per basic and diluted share on sales of $49,722,000 against net loss of $63,139,000 or $21.46 per basic and diluted share on sales of $29,007,000 a year ago. Operating loss of $75,664,000 compared to $49,434,000 a year ago. Loss before taxes of $79,453,000 compared to $63,139,000 a year ago. For the year ending December 31, 2015, the company is providing its guidance as follows: sales are estimated to be in the range of $70.0 million to $75.0 million, which includes $1.0 million to $3.0 million of t:flex Insulin Pump sales, and operating margin is estimated to be in the range of negative 100% to negative 110%, which includes approximately $13.0 million to $14.0 million in non-cash stock-based compensation expense.

Tandem Diabetes Care, Inc. to Report Q4, 2014 Results on Feb 24, 2015

Tandem Diabetes Care, Inc. announced that they will report Q4, 2014 results After-Market on Feb 24, 2015

Tandem Diabetes Care, Inc., Q4 2014 Earnings Call, Feb 24, 2015

Tandem Diabetes Care, Inc., Q4 2014 Earnings Call, Feb 24, 2015

Similar Private Companies By Industry

Company Name Region
Kinetic Muscles, Inc. United States
Maxim Biomedical, Inc. United States
Complete Care Medical, Inc. United States
Softscope Medical Technologies, Inc. United States
International BioMedical Devices, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tandem Diabetes Care, Inc., please visit www.tandemdiabetes.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.